← Every company
Oramed Pharmaceuticals Inc Patents
What Oramed Pharmaceuticals Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
ORMP on carbonthat →Filings on file
2
Granted
0
Still pending
2
Filed under
1 names
2 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| Methods and Compositions for Oral Administration of ProteinsA61K 38/28, A61K 9/0053, A61K 9/2013, A61K 9/2068, A61K 9/2846, A61K 9/2866, A61K 9/485, A61K 9/4866, A61K 9/4875, A61K 9/4891, A61K 9/5057, A61K 31/202, A61K 31/22, A61K 35/60, A61K 38/56, A61K 45/06, A61K 47/28, A61P 43/00, A61P 3/10, A61K2300/00Filed as ORAMED PHARMACEUTICALS INC.2024-10-21Miriam KIDRON | pending |
| Methods and Compositions for Oral Administration of ProteinsFiled as ORAMED PHARMACEUTICALS INC.2024-03-07Miriam KIDRON | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on ORMP
Company overviewEverything on ORMP in one place, with the price.SEC filingsWhat ORMP's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ORMP's own officers and directors buy and sell.Executive payWhat ORMP awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ORMP.Funds holding itWhich funds and ETFs hold ORMP, and how big a bet.